Clinical trial
Tipifarnib in Treating Patients With Anemia or Neutropenia and Large Granular…
NCT00360776 · National Cancer Institute (NCI), NIH · Terminated
Key facts
| NCT number | NCT00360776 |
|---|---|
| Title | Tipifarnib in Treating Patients With Anemia or Neutropenia and Large Granular Lymphocyte Leukemia |
| Official title | A Phase 2 Study of Tipifarnib in Large Granular Lymphocyte (LGL) Leukemia |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Stage III Chronic Lymphocytic Leukemia, Stage IV Chronic Lymphocytic Leukemia, T-cell Large Granular Lymphocyte Leukemia |
| Intervention type | Drug, Other |
| Interventions | tipifarnib, laboratory biomarker analysis |
| Enrollment | 25 |
| Start date | Jun 2, 2006 |
| Primary completion | May 14, 2007 |
| First posted | Aug 7, 2006 |
| Last update posted | Apr 5, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: